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Circulation 2012;126:3054-61.Submitted Feb 22, 2013; accepted Apr 5, 2013.INVITED COMMENTARYWilliam C. Mackey, MD, Boston, MassIn this retrospective study, Samson and colleagues present
excellent results (2% neurologic event rate, 0.7% mortality, and
no clinically apparent myocardial infarctions) in 147 consecu-
tive contralateral carotid occlusion patients, who underwent
carotid endarterectomy (CEA) without shunting. They attri-
bute their success to the use of general anesthesia with careful
maintenance of systolic blood pressure above 130 mm Hg.
Their results add fuel to the controversies over neurologic
risk in contralateral occlusion patients and over the role of
shunting.
While provocative, the study is not deﬁnitive. It suffers from
the weaknesses inherent in retrospective analyses. The credibility
of the outcome data suffers from the absence of independent
routine pre- and post-CEA neurologic assessment and of a set
protocol for post-CEA brain imaging. It is almost certain that
there were more perioperative strokes than they report, though
these events were clinically silent or subtle. Furthermore, given
the authors’ use of phenylephrine-induced hypertension as
a means of cerebral protection, their failure to routinely monitor
postoperative cardiac enzymes represents a missed opportunity to
conﬁrm the safety of their protocol. Theoretically, at least, the
routine use of vasopressors will add to the hemodynamic stressof the surgery, thereby raising the risk of perioperative cardiac
morbidity.
Despite these shortcomings, this report conﬁrms four facts:
(1) Well-trained surgeons, working with detail-oriented anesthesi-
ologists and adhering to well-deﬁned management protocols, can
achieve excellent results with CEA even in putatively high-risk
patients. (2) CEA patients with contralateral occlusion are not
necessarily at high neurologic risk. (3) The argument that contra-
lateral occlusion represents an indication for carotid stenting is
specious. (4) Contralateral occlusion is not an absolute indication
for shunt placement during CEA.
The report does not establish the superiority of the authors’
practices, but it does establish their management protocol as one
acceptable approach to the management of CEA patients with
contralateral occlusion. Those who achieve excellent results in
this patient population with carotid stenting or with CEA with
shunting are not likely to be converted by these data, but now
have another standard against which to measure their outcomes.
Controversy over the risk associated with contralateral occlusion
and the role of shunting will continue. In the face of ongoing
controversy, surgeons will continue to adopt and report those
practices that provide optimal results for their patients.
